SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001824299-20-000002
Filing Date
2020-09-11
Accepted
2020-09-11 15:14:08
Documents
1
Effectiveness Date
2020-09-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6066
  Complete submission text file 0001824299-20-000002.txt   7262
Mailing Address 535 W RESEARCH CENTER BLVD SUITE 135 FAYETTEVILLE AR 72701
Business Address 535 W RESEARCH CENTER BLVD SUITE 135 FAYETTEVILLE AR 72701 4795212592
VIN-16 Neurexis Therapeutics, LLC (Filer) CIK: 0001824299 (see all company filings)

IRS No.: 844983814 | State of Incorp.: AR | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-375346 | Film No.: 201170765